Trial Profile
Evaluating the efficacy of Memantine on improving Cognitive Functions in Epileptic Patients receiving Anti-Epileptic Drugs: A double blind placebo controlled clinical study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 25 Oct 2013 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
- 26 Jul 2013 New trial record